DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Chupp GL, Bradford ES, Albers FC. , et al.
Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial.
Lancet Respir Med 2017;
5 (05) 390-400
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.